Bosch, Jaime

Baveno VII – Renewing consensus in portal hypertension

de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J. G., Albillos, A., Baiges, A., Bajaj, J., Bañares, R., et al. (2022) · Journal of Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 2,930

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management 2016 practice guidance by the American Association for the study of liver diseases

Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology

Liver Disease and TransplantationGastrointestinal Bleeding Diagnosis and Treatment

Cited by 2,154

Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis

Ripoll, C., Groszmann, R., Garcia–Tsao, G., Grace, N., Burroughs, A., Planas, R., Escorsell, A., Garcia–Pagan, J. C., Makuch, R., Patch, D., et al. (2007) · Gastroenterology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 1,183

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Sanyal, A. J., Harrison, S. A., Ratziu, V., Abdelmalek, M. F., Diehl, A. M., Caldwell, S., Shiffman, M. L., Aguilar Schall, R., Jia, C., McColgan, B., et al. (2019) · Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 390

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Harrison, S. A., Abdelmalek, M. F., Caldwell, S., Shiffman, M. L., Diehl, A. M., Ghalib, R., Lawitz, E. J., Rockey, D. C., Schall, R. A., Jia, C., et al. (2018) · Gastroenterology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 384

Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis

Abraldes, J. G., Villanueva, C., Aracil, C., Turnes, J., Hernandez-Guerra, M., Genesca, J., Rodriguez, M., Castellote, J., García-Pagán, J. C., Torres, F., et al. (2016) · Gastroenterology

Liver Disease and TransplantationGastrointestinal Bleeding Diagnosis and Treatment

Cited by 339

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study

Berzigotti, A., Albillos, A., Villanueva, C., Genescá, J., Ardevol, A., Augustín, S., Calleja, J. L., Bañares, R., García‐Pagán, J. C., Mesonero, F., et al. (2017) · Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 334

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

Berzigotti, A., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Morillas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., et al. (2011) · Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 325

Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease

Pons, M., Augustin, S., Scheiner, B., Guillaume, M., Rosselli, M., Rodrigues, S. G., Stefanescu, H., Ma, M. M., Mandorfer, M., Mergeay-Fabre, M., et al. (2021) · American Journal of Gastroenterology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 260

Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis

Dominguez, M., Miquel, R., Colmenero, J., Moreno, M., García–Pagán, J., Bosch, J., Arroyo, V., Ginès, P., Caballería, J., & Bataller, R. (2009) · Gastroenterology

Alcohol Consumption and Health EffectsLiver physiology and pathology

Cited by 238

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins

Marrone, G., Maeso-Díaz, R., García-Cardena, G., Abraldes, J. G., García-Pagán, J. C., Bosch, J., & Gracia-Sancho, J. (2015) · Gut

Liver physiology and pathologyLiver Disease and Transplantation

Cited by 222

Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis

Bellot, P., Garc´ıa-Paga´n, J. C., France´s, R., Abraldes, J. G., Navasa, M., Pe´rez-Mateo, M., Such, J., & Bosch, J. (2010) · Hepatology

Liver Disease and TransplantationSepsis Diagnosis and Treatment

Cited by 219

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

Sanyal, A. J., Anstee, Q. M., Trauner, M., Lawitz, E. J., Abdelmalek, M. F., Ding, D., Han, L., Jia, C., Huss, R. S., Chung, C., et al. (2022) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 171

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

Boyer-Diaz, Z., Aristu-Zabalza, P., Andrés-Rozas, M., Robert, C., Ortega-Ribera, M., Fernández-Iglesias, A., Broqua, P., Junien, J.-L., Wettstein, G., Bosch, J., et al. (2021) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 168

Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers

Gracia-Sancho, J., Laviña, B., Rodríguez-Vilarrupla, A., García-Calderó, H., Bosch, J., & García-Pagán, J. C. (2007) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 125

Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

Loomba, R., Huang, D. Q., Sanyal, A. J., Anstee, Q. M., Trauner, M., Lawitz, E. J., Ding, D., Ma, L., Jia, C., Billin, A., et al. (2023) · Gut

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 110